Advances in Clinical and Experimental Medicine

Adv Clin Exp Med
Impact Factor (IF) – 1.514
Index Copernicus (ICV 2018) – 157.72
MNiSW – 40
Average rejection rate – 84.38%
ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download PDF

Advances in Clinical and Experimental Medicine

2018, vol. 27, nr 11, November, p. 1567–1572

doi: 10.17219/acem/74653

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Creative Commons BY-NC-ND 3.0 Open Access

Circulating parameters of oxidative stress and hypoxia in normal pregnancy and HELLP syndrome

Ahmet Mentese1,A,B,C,D,F, Süleyman Güven2,A,D,F, Selim Demir3,B,C,D, Ayşegül Sümer4,B,C, Serap Özer Yaman5,B,C, Ahmet Alver5,A,E,F, Mehmet Sonmez6,A,E,F, Süleyman Caner Karahan5,A,E,F

1 Program of Medical Laboratory Techniques, Vocational School of Health Sciences, Karadeniz Technical University, Trabzon, Turkey

2 Department of Obstetrics and Gynecology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey

3 Department of Nutrition and Dietetics, Faculty of Health Sciences, Karadeniz Technical University, Trabzon, Turkey

4 Department of Nursing, School of Health Services, Recep Tayyip Erdogan University, Rize, Turkey

5 Department of Medical Biochemistry, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey

6 Department of Hematology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey


Background. The HELLP syndrome (Hemolysis, Elevated Liver enzymes and Low Platelets) is a complication of severe pre-eclampsia, a condition characterized by oxidative stress elevation caused by disequilibrium between lipid peroxidation and antioxidant defense mechanisms, which, in turn, results in endothelial compromise and free radical-mediated cell damage. While several studies have examined the relationship between pre-eclampsia and oxidative stress, research investigating oxidative and hypoxic status in HELLP syndrome is limited.
Objectives. The aim of this study was to compare the levels of oxidative stress markers – total oxidant status (TOS), total antioxidant status (TAS), oxidative stress index (OSI), and malondialdehyde (MDA) – and a hypoxia marker – carbonic anhydrase IX (CA IX) – in patients with HELLP syndrome and in healthy pregnant women.
Material and Methods. A total of 23 women with HELLP syndrome and 30 healthy pregnant women were included in the study. Serum levels of oxidative stress markers were determined using colorimetric methods, while serum levels of CA IX were measured using an enzyme-linked immunosorbent assay (ELISA) kit.
Results. The TOS, OSI, MDA, and CA IX levels were significantly higher in women with HELLP syndrome than in the controls (p = 0.0001, p = 0.0001, p = 0.0001, and p = 0.008, respectively).
Conclusion. Increased levels of oxidative stress and hypoxia markers in women with HELLP syndrome suggest that oxidative stress and hypoxia may be significantly involved in the pathophysiology of the disease. Further follow-up studies are now needed to investigate the prognostic roles of these parameters in patients with HELLP syndrome.

Key words

oxidative stress, carbonic anhydrases, hypoxia, HELLP syndrome

References (25)

  1. Weinstein L. Syndrome of hemolysis, elevated liver enzymes and low platelet count: A severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982;142(2):159–167.
  2. Pokharel SM, Chattopadhyay SK, Jaiswal R, Shakya P. HELLP syndrome: A pregnancy disorder with poor prognosis. Nepal Med Coll J. 2008;10(4):260–263.
  3. Basturk M, Tokgoz O, Evsen MS, et al. Emergency approach in HELLP syndrome. J Emerg Med. 2009;8(1):9–12.
  4. Benedetto C, Marozio L, Tancredi A, et al. Biochemistry of HELLP syndrome. Adv Clin Chem. 2011;53:85–104.
  5. Guven S, Sonmez M, Karahan SC. The role of fibrinolytic and antifibrinolytic activities in the pathophysiology of HELLP syndrome. Hypertens Pregnancy. 2011;30(3):275–286.
  6. Brosens JJ, Pijnenborg R, Brosens IA. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: A review of the literature. Am J Obstet Gynecol. 2002;187(5):1416–1423.
  7. Hansson SR, Naav A, Erlandsson L. Oxidative stress in preeclampsia and the role of free fetal hemoglobin. Front Physiol. 2015;5:516.
  8. Pisoschi AM, Pop A. The role of antioxidants in the chemistry of oxidative stress: A review. Eur J Med Chem. 2015;97:55–74.
  9. Weidinger A, Kozlov AV. Biological activities of reactive oxygen and nitrogen species: Oxidative stress versus signal transduction. Biomolecules. 2015;5(2):472–484.
  10. Siddiqui IA, Jaleel A, Tamimi W, Al Kadri HM. Role of oxidative stress in the pathogenesis of preeclampsia. Arch Gynecol Obstet. 2010;282: 469–474.
  11. Zusterzeel PL, Rutten H, Roelofs HM, Peters WH, Steegers EA. Protein carbonyls in decidua and placenta of pre-eclamptic women as markers for oxidative stress. Placenta. 2001;22(2–3):213–219.
  12. Torrance HL, Krediet TG, Vreman HJ, Visser GH, van Bel F. Oxidative stress and proinflammatory cytokine levels are increased in premature neonates of preeclamptic mothers with HELLP syndrome. Neonatology. 2008;94(2):138–142.
  13. Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: Clinical issues and management: A review. BMC Pregnancy Childbirth. 2009;9:8.
  14. Yagi K. Lipid peroxides and related radicals in clinical medicine. In: Armstrong D, ed. Free Radicals in Diagnostic Medicine. New York, NY: Plenum Press; 1994:1–15.
  15. Turkmen S, Mentese S, Mentese A, et al. The value of signal peptide-CUB-EGF domain-containing protein 1 and oxidative stress parameters in the diagnosis of acute mesenteric ischemia. Acad Emerg Med. 2013;20(3):257–264.
  16. Glanville T, WaIker J. HELLP syndrome. Obstet Gynecol. 2003;5:149–154.
  17. Sharma JB, Sharma A, Bahadur A, Vimala N, Satyam A, Mittal S. Oxidative stress markers and antioxidant levels in normal pregnancy and pre-eclampsia. Int J Gynaecol Obstet. 2006;94(1):23–27.
  18. Sanchez-Aranguren LC, Prada CE, Riano-Medina CE, Lopez M. Endothelial dysfunction and preeclampsia: Role of oxidative stress. Front Physiol. 2014;5(372):1–11.
  19. Chamy VM, Lepe J, Catalan A, Retamal D, Escobar JA, Madrid EM. Oxidative stress is closely related to clinical severity of pre-eclampsia. Biol Res. 2006;39(2):229–236.
  20. Mohanty S, Sahu PK, Mandal MK, Mohapatra PC, Panda A. Evaluation of oxidative stress in pregnancy induced hypertension. Indian J Clin Biochem. 2006;21(1):101–105.
  21. Vanitha Gowda MN, Aroor AR, Krishna L. Studies on oxidative stress in preeclampsia. Biomed Res. 2010;21(1):71–79.
  22. Khatri M. Circulating biomarkers of oxidative stress in normal pregnancy and preeclampsia and efficacy of antioxidant supplementation. Int J Reprod Contracept Obstet Gynecol. 2013;2(3):304–310.
  23. Ambrosio MR, Di Serio C, Danza G, et al. Carbonic anhydrase IX is a marker of hypoxia and correlates with higher Gleason scores and ISUP grading in prostate cancer. Diagn Pathol. 2016;11:45.
  24. Potter C, Harris AL. Hypoxia inducible carbonic anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target. Cell Cycle. 2004;3(2):164–167.
  25. Tal R. The role of hypoxia and hypoxia-inducible factor-1 alpha in preeclampsia pathogenesis. Biol Reprod. 2012;87(6):134.